Ocr-mediated suppression of BrxX unveils a phage counter-defense mechanism
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Shen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-…. Hauptthemen laut MEDLINE: Escherichia coli, Escherichia coli Proteins, Viral Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
The burgeoning crisis of antibiotic resistance has directed attention to bacteriophages as natural antibacterial agents capable of circumventing bacterial defenses. Central to this are the bacterial defense mechanisms, such as the BREX system, which utilizes the methyltransferase BrxX to protect against phage infection. This study presents the first in vitro characterization of BrxX from Escherichia coli, revealing its substrate-specific recognition and catalytic activity. We demonstrate that BrxX exhibits nonspecific DNA binding but selectively methylates adenine within specific motifs. Kinetic analysis indicates a potential regulation of BrxX by the concentration of its co-substrate, S-adenosylmethionine, and suggests a role for other BREX components in modulating BrxX activity. Furthermore, we elucidate the molecular mechanism by which the T7 phage protein Ocr (Overcoming classical restriction) inhibits BrxX. Despite low sequence homology between BrxX from different bacterial species, Ocr effectively suppresses BrxX’s enzymatic activity through high-affinity binding. Cryo-electron microscopy and biophysical analyses reveal that Ocr, a DNA mimic, forms a stable complex with BrxX, highlighting a conserved interaction interface across diverse BrxX variants. Our findings provide insights into the strategic counteraction by phages against bacterial defense systems and offer a foundational understanding of the complex interplay between phages and their bacterial hosts, with implications for the development of phage therapy to combat antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen 518107, China.
- Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou 730000, China.
- Electron Microscopy Centre of Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Litao Sun
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Gansu Province
- Natural Science Foundation of Guangdong Province
- Shenzhen Science and Technology Program
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Li, S., Xu, T., Meng, X., Yan, Y., Zhou, Y., Duan, L., Tang, Y., Zhu, L., & Sun, L. (2024). Ocr-mediated suppression of BrxX unveils a phage counter-defense mechanism. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae608
Vancouver
Li S, Xu T, Meng X, Yan Y, Zhou Y, Duan L, et al. Ocr-mediated suppression of BrxX unveils a phage counter-defense mechanism. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae608
BibTeX
@article{Li2024,
author = {Li, Shen and Xu, Tianhao and Meng, Xinru and Yan, Yujuan and Zhou, Ying and Duan, Lei and Tang, Yulong and Zhu, Li and Sun, Litao},
title = {Ocr-mediated suppression of BrxX unveils a phage counter-defense mechanism},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae608}
}
EUVIMED